When it comes to CLL/SLL treatment, what’s the difference between BTK inhibitors and BCL-2 inhibitors? Understanding how these treatment approaches work and how they fit into the treatment…
BTK degrader BGB-16673 reduced tumor burden in 85% of patients from a high-risk, hard-to-treat group with relapsed / refractory CLL. Dr. Stephan Stilgenbauer from Ulm University and colleagues…
Hepatitis C is an RNA flavivirus that infects 4 million people in the United States, making it the leading indicator for liver transplant in the US. It has…
Researchers in South Korea have developed micro-robots (about 0.3 millimeters wide) that can be magnetically manipulated by physicians after injection to maximize stem cell delivery to the desired…
Researchers working within the University of New South Wales‘ (UNSW) Journey to the Centre of the Cell project have made great strides in 3D renderings that will allow…
Approximately one-third of patients with Huntington’s disease (HD) experience depression. In 21 published case reports where electroconvulsive therapy (ECT) was used to treat depression in patients with HD,…
The Keep Her Awesome initiative was designed to raise awareness around vaginal health issues and stress the importance of consulting a medical professional for health advice. According to…
Many patients with neurodevelopmental disorders also exhibit psychiatric issues that can negatively affect their livelihood and the lives of those around them. Collaboration is an important element in…
